Skip to main content
Toggle navigation
Login
Search
Home
Back
Favorite
0
Like
Facebook
Tweet
Print
Session VI: ALL
Debate: Best Therapy For ALL In First Relapse Or Disease Refractory To Standard Treatment - Ab
Thursday, May 12, 2022
11:50 AM – 12:05 PM
Debate Speaker(s)
Shira Dinner, MD
Associate Professor
Northwestern University
Chicago, Illinois
Learning Objectives:
Identify the molecular targets for currently available treatments for R/R ALL
Summarize key efficacy and safety data for approved therapeautic regimens for R/R ALL